Clin­i­cal tri­als at lo­cal phar­ma­cies? A nat­ur­al fit and more like­ly than ever: an­a­lyst

Dur­ing the Covid-19 pan­dem­ic, lo­cal phar­ma­cies were not on­ly key pur­vey­ors of pre­scrip­tions and hand san­i­tiz­er, but al­so im­por­tant test­ing and vac­cine de­liv­ery lo­ca­tions. Next up? Clin­i­cal tri­al sites. That’s ac­cord­ing to a re­cent PwC Health re­port that lays out the case for both phar­ma and phar­ma­cies — and why it’s more prob­a­ble than ever.

Fig­ur­ing out how to scale de­cen­tral­ized tri­als is nec­es­sary, made clear by the pan­dem­ic, said Greg Rotz, PwC’s phar­ma and life sci­ences part­ner in the US. The good news from his per­spec­tive is both phar­ma com­pa­nies and re­tail­ers are in­vest­ing in busi­ness mod­els and in­fra­struc­ture to make it hap­pen.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER